Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Karagiannis, Asterios [Clear All Filters]
(2019).
(2019).
(2019).
Antihypertensive therapy in acute ischemic stroke: where do we stand?.
J Hum Hypertens. 32(12), 799-807.
(2018). Boosting the Limited Use of Mineralocorticoid Receptor Antagonists Through New Agents for Hyperkalemia..
Curr Pharm Des. 24(46), 5542-5547.
(2018). Diabetes and lipid metabolism..
Hormones (Athens). 17(1), 61-67.
(2018). Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?.
Maturitas. 108, 45-52.
(2018). The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data..
Hormones (Athens). 17(1), 83-95.
(2018). Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension..
Curr Vasc Pharmacol. 16(4), 393-400.
(2018). Pharmacotherapy of type 2 diabetes: An update..
Metabolism. 78, 13-42.
(2018). Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?.
J Clin Hypertens (Greenwich). 20(5), 942-948.
(2018). Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?.
J Clin Hypertens (Greenwich). 20(4), 634-636.
(2018). Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice..
Cardiovasc Hematol Disord Drug Targets. 18(2), 139-146.
(2018). Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?.
J Hypertens. 36(3), 701.
(2018). Acute Coronary Syndrome in Patients With Inflammatory Bowel Diseases: The Plaque and the Thrombus..
Angiology. 68(10), 843-844.
(2017). Blood pressure and cardiovascular outcomes: a closer look..
Lancet. 389(10076), 1295-1296.
(2017). The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins..
Curr Pharm Des. 23(10), 1477-1483.
(2017). The effect of SGLT2 inhibitors on cardiovascular events and renal function..
Expert Rev Clin Pharmacol. 10(11), 1251-1261.
(2017). Mortality reduction in patients treated with intensive lipid therapy vs usual care. Re: Zhao XQ, Phan BA, Davis J et al. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Tre.
J Clin Lipidol. 11(1), 306-307.
(2017). Randomized, controlled, multicentre clinical trial of the antipyretic effect of intravenous paracetamol in patients admitted to hospital with infection..
Br J Clin Pharmacol. 83(4), 742-750.
(2017). Semaglutide, lipid-lowering drugs, and NAFLD..
Lancet Diabetes Endocrinol. 5(5), 329-330.
(2017). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017).
(2017).
(2017).
(2016).